Astera Labs Inc
NASDAQ:ALAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Astera Labs Inc
NASDAQ:ALAB
|
US |
|
P
|
Pfizer Inc
F:PFE
|
US |
|
S
|
S&P Global Inc
XMUN:MHL
|
US |
|
Aytu Biopharma Inc
NASDAQ:AYTU
|
US |
|
Guaranty Trust Holding Company PLC
LSE:GTCO
|
NG |
|
BASF India Ltd
BSE:500042
|
IN |
|
Caravel Minerals Ltd
ASX:CVV
|
AU |
|
B
|
Biotest AG
XETRA:BIO2
|
DE |
|
Hindalco Industries Ltd
NSE:HINDALCO
|
IN |
|
Rashtriya Chemicals and Fertilizers Ltd
NSE:RCF
|
IN |
Wall St Price Targets
ALAB Price Targets Summary
Astera Labs Inc
According to Wall Street analysts, the average 1-year price target for ALAB is 246.06 USD with a low forecast of 154.86 USD and a high forecast of 311.85 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ALAB's stock price target?
Price Target
246.06
USD
According to Wall Street analysts, the average 1-year price target for ALAB is 246.06 USD with a low forecast of 154.86 USD and a high forecast of 311.85 USD.
What is the Revenue forecast for Astera Labs Inc?
Projected CAGR
25%
Over the last 2 years, the compound annual growth rate for Revenue has been 171%. The projected CAGR for the next 5 years is 25%.
What is the Operating Income forecast for Astera Labs Inc?
Projected CAGR
51%
The compound annual growth rate for Operating Income over the next 4 years is 51%.
What is the Net Income forecast for Astera Labs Inc?
Projected CAGR
37%
The compound annual growth rate for Net Income over the next 4 years is 37%.
